Vaccination campaigns against the Coronavirus are being conducted in many countries of the world, including Britain and America, but when it will happen in India, it is not yet clear and it is not known which vaccine is the first in the country. Will be approved. But it is likely that the Oxford-AstraZeneca vaccine may get the first emergency use approval in India. According to government sources, the Subject Expert Committee of the Central Drug Standards Control Organization is expected to examine the application submitted by the Serum Institute of India this week. Indeed, the Serum Institute is manufacturing and testing the Oxford-AstraZeneca vaccine in India.
It is believed that in Britain, the drug regulator may approve Oxford's 'covishield' vaccine next week. It is being told that Indian authorities are waiting for the decision of the British drug regulator. As soon as it is approved for its use, its process will be started in India as well.
According to reports, the Serum Institute has recently provided additional data related to the vaccine sought by drug regulator DCGI. On December 9, the Subject Expert Committee of the Central Drugs Standard Control Organization asked the Serum Institute for additional data on the safety and effectiveness of the vaccine.
According to media reports, AstraZeneca chief executive Pascal Soriot has claimed that the Corona vaccine produced by Oxford-AstraZeneca will provide 95 percent protection against the virus. This will be as effective as the Pfizer and Moderna vaccines.
Will, this vaccine work on Corona's new strain?
According to Pascal Soriot, this Oxford-AstraZeneca vaccine is 100 percent effective in preventing health and preventing hospitalization. He said that this vaccine should also be effective against the new strain (type) of the corona, which is believed to be 70 percent more contagious.